CUAMC
China Universal Asset Management Company’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Buy |
15,312
+90
| +0.6% | +$1.03K | 0.02% | 322 |
|
|
2025
Q1 | $181K | Buy |
15,222
+202
| +1% | +$2.4K | 0.02% | 320 |
|
|
2024
Q4 | $283K | Buy |
15,020
+2,632
| +21% | +$49.6K | 0.03% | 300 |
|
|
2024
Q3 | $278K | Buy |
12,388
+5,419
| +78% | +$122K | 0.03% | 275 |
|
|
2024
Q2 | $145K | Sell |
6,969
-2,435
| -26% | -$50.8K | 0.02% | 272 |
|
|
2024
Q1 | $138K | Buy |
9,404
+3,793
| +68% | +$55.8K | 0.02% | 338 |
|
|
2023
Q4 | $57.9K | Buy |
5,611
+4,367
| +351% | +$45.1K | 0.01% | 355 |
|
|
2023
Q3 | $9.78K | Buy |
1,244
+622
| +100% | +$4.89K | ﹤0.01% | 347 |
|
|
2023
Q2 | $6.21K | Sell |
622
-19
| -3% | -$190 | ﹤0.01% | 349 |
|
|
2023
Q1 | $5.69K | Buy |
641
+162
| +34% | +$1.44K | ﹤0.01% | 352 |
|
|
2022
Q4 | $5.26K | Buy |
479
+39
| +9% | +$428 | ﹤0.01% | 292 |
|
|
2022
Q3 | $6K | Buy |
+440
| New | +$6K | ﹤0.01% | 260 |
|